Results 101 to 110 of about 18,732 (296)

COVID-19 Newsletter (Vol. 153) [PDF]

, 2023
https://touroscholar.touro.edu/nymc_covid19_newsletter/1148/thumbnail ...
Center for Disaster Medicine, New York Medical College
core   +1 more source

Vaccines against mpox: MVA-BN and LC16m8

Expert Review of Vaccines
Introduction Global outbreaks involving mpox clade IIb began in mid-2022. Today, clade IIb and clade I outbreaks continue. Reliable mpox vaccines can prevent serious mpox disease and death.
John D. Grabenstein, Adam Hacker
semanticscholar   +1 more source

A theory-based assessment of mpox: Findings from a nationally representative survey of U.S. adults.

PLoS ONE
The purpose of this research was to examine individual differences related to fear of, perceived susceptibility to, and perceived severity of mpox as well as mpox knowledge, fear, perceived susceptibility, and perceived severity as predictors of vaccine ...
Margaret L Walsh-Buhi, Rebecca F Houghton, Danny Valdez, Eric R Walsh-Buhi   +3 more
doaj   +1 more source

Scenarios of future mpox outbreaks among men who have sex with men:a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022 [PDF]

Background: Following the 2022–2023 mpox outbreak, crucial knowledge gaps exist regarding orthopoxvirus-specific immunity in risk groups and its impact on future outbreaks.
de Vries, Rory D., GeurtsvanKessel, Corine H., Götz, Hannelore M., Hoornenborg, Elske, Jonas, Kai J., Koopmans, Marion P.G., Shamier, Marc C., van Cleef, Brigitte A.G.L., van de Vijver, David A.M.C., van Royen, Martin E., Verstrepen, Babs E., Vieyra, Bruno, Welkers, Matthijs R.A., Wijnans, Koen, Zaeck, Luca M.   +14 more
core   +1 more source

Mpox outbreak among men who have sex with men in Amsterdam and Rotterdam, the Netherlands: no evidence for undetected transmission prior to May 2022, a retrospective study [PDF]

, 2023
Henry J.C. de Vries, Hannelore M Götz, Sylvia M. Bruisten, Annemiek A. van der Eijk, Maria Prins, Bas B. Oude Munnink, Matthijs R. A. Welkers, Marcel Jonges, Richard Molenkamp, Brenda M. Westerhuis, Leonard Schuele, Arjen Stam, Marjan Boter, Elske Hoornenborg, Daphne G.J.C. Mulders, Mariken van den Lubben, Marion Koopmans   +16 more
openalex   +1 more source

Predicting vaccine effectiveness for mpox

Nature Communications
The Modified Vaccinia Ankara vaccine developed by Bavarian Nordic (MVA-BN) was widely deployed to prevent mpox during the 2022 global outbreak. This vaccine was initially approved for mpox based on its reported immunogenicity (from phase I/II trials) and
Matthew T. Berry, Shanchita R Khan, T. Schlub, A. Notaras, M. Kunasekaran, Andrew E Grulich, C. R. MacIntyre, Miles P. Davenport, D. Khoury   +8 more
semanticscholar   +1 more source

Prvi slučaj dokazane importirane mpox infekcije u Splitu u srpnju 2022. godine

, 2022
Karabuva, Svjetlana, Trogrlić, Antea, Kaliterna, Vanja, Nonković, Diana   +3 more
openalex   +1 more source

The Re-Emergence of Mpox: Old Illness, Modern Challenges

Biomedicines
The Mpox virus (MPXV) is known to cause zoonotic disease in humans. The virus belongs to the genus Orthopoxvirus, of the family Poxviridae, and was first reported in monkeys in 1959 in Denmark and in humans in 1970 in the Congo.
M. A. Zinnah, Md Bashir Uddin, Tanjila Hasan, Shobhan Das, Fahima Khatun, Md Hasibul Hasan, Ruenruetai Udonsom, Md. Masudur Rahman, Hossam M. Ashour   +8 more
semanticscholar   +1 more source

An assessment of awareness, knowledge and perception of monkeypox (mpox) disease among internet users in Nigeria: a cross-sectional survey [PDF]

Objectives: This study aimed to assess knowledge and perception of mpox among internet users in Nigeria.Methods: This was a cross-sectional survey guided by the health belief model (HBM).
AA, Bakare, Bakare, Damola, Olojede, Omotayo, Salako, Julius, Sogbesan, Abiodun   +4 more
core   +1 more source

The response of mpox-associated inflammatory syndrome to steroid therapy [PDF]

, 2023
César A. Arias, William R. Miller, Randall J. Olsen, Jimmy Gollihar, Andrea Armstrong   +4 more
openalex   +1 more source